AquaBounty Technologies, Inc. Announces Second Quarter 2022 Financial Results

In this article:
AquaBounty Technologies, Inc.AquaBounty Technologies, Inc.
AquaBounty Technologies, Inc.

MAYNARD, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the second quarter ended June 30, 2022.

Second Quarter 2022 Highlights and Recent Developments

  • Generated $1.1 million in product revenue in the second quarter, a year-over-year increase of 371% as compared to $227 thousand in the second quarter of 2021.

  • Net loss in the second quarter totaled $5.5 million, as compared to $5.2 million in the second quarter of 2021.

  • Construction activities for the Pioneer, Ohio farm site are well underway and now focused on underground piping.

  • Cash, cash equivalents, marketable securities and restricted cash totaled $149.2 million as of June 30, 2022, as compared to $191.2 million as of December 31, 2021.

Management Commentary

“Our genetically engineered Atlantic salmon saw continued market validation from seafood distributors in the quarter, with strong demand continuing for the entire output of our Indiana farm,” said Sylvia Wulf, Chief Executive Officer of AquaBounty. “This robust demand, combined with improvements in our sales yields and higher market prices, drove an 11% sequential increase in second quarter revenues to $1.1 million. As we ramp production at our Indiana facility, we will continue to utilize the farm as an opportunity to refine our production and harvest methods through the application of technology and process improvements – a critical learning experience ahead of our Ohio farm.

“Construction progress on our next-generation farm in Pioneer, Ohio is advancing. After the groundbreaking ceremony in late April, work commenced on initial pre-construction activities including the construction of roadways, on-site energy infrastructure and land preparation. With that work largely complete, we are now focused on excavating the ground site and laying the piping that will provide fresh water to our fish tanks.

“On the bond financing front, we have decided to slow the process down temporarily in order to evaluate the current economic forces that are driving both inflation and interest rates higher. Since our estimate for construction of the farm currently exceeds our previous range of $290 - $320 million, we will review all options for reducing cost, including potentially phasing the construction of the 10,000 metric ton farm with an initial production output level that would demonstrate our competitive advantage and ability to operate at commercial scale. We believe this is a prudent move and it will allow us to re-estimate remaining construction costs and thus avoid locking in contracts, commodity pricing for materials or interest rates at what may be their peak. We currently expect to resume our bond financing efforts with Wells Fargo Corporate and Investment Banking and the issuance of additional construction sub-contracts, once we have completed our evaluation of the project scope, relevant economic trends and market costs. However, construction on the farm will continue during this period and we are targeting to close the bond financing by year-end.

“As we look to the second half of 2022, we are operating from a strong position. Our GE Atlantic salmon continues to receive market validation, the scale-up of harvests and sales at our Indiana facility is well underway, and construction continues at the Ohio farm – all supported by our fortified balance sheet. We are committed to bringing a high-volume of fresh, sustainable Atlantic salmon to the market and look forward to continued execution and foundation building in the months ahead as we strive to build long-term value for our shareholders,” concluded Wulf.

About AquaBounty

At AquaBounty Technologies, Inc. (NASDAQ: AQB), we believe we are a leader in land-based aquaculture leveraging decades of technology expertise to deliver disruptive solutions that address food insecurity and climate change issues. We are committed to feeding the world efficiently, sustainably and profitably. AquaBounty provides fresh Atlantic salmon to nearby markets by raising its fish in carefully monitored land-based fish farms through a safe, secure and sustainable process. The Company’s land-based Recirculating Aquaculture System (“RAS”) farms, located in Indiana, United States and Prince Edward Island, Canada, are close to key consumption markets and are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. AquaBounty is raising nutritious salmon that is free of antibiotics and contaminants and provides a solution resulting in a reduced carbon footprint and no risk of pollution to marine ecosystems as compared to traditional sea-cage farming. For more information on AquaBounty, please visit www.aquabounty.com or follow us on Facebook, Twitter, LinkedIn and Instagram.

Forward-Looking Statements

This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995, as amended, including regarding the anticipated size of AquaBounty’s proposed facility in Ohio; production capacity; timing of construction, permits, regulatory approvals, or commercial stocking; cost of construction; ability to scale commercial production; the timing of the contemplated bond financing; future revenue streams; onboarding customers, pricing and profitability; customer sentiment; and technological capabilities.  The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these statements because they involve significant risks and uncertainties about AquaBounty. AquaBounty may use words such as “expect,” “anticipate,” “project,” “intend,” “slated to,” “plan,” “aim,” “believe,” “seek,” “estimate,” “can,” “focus,” “will,” “may,” the negative forms of these words and similar expressions to identify such forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are risks relating to, among other things, whether AquaBounty will be able to secure required regulatory approvals and permits; be able to profitably construct and operate the Pioneer, Ohio farm; be able to operate its Albany, Indiana and Prince Edward Island farms; AquaBounty’s business and financial condition; and the impact of general economic, public health, industry or political conditions in the United States and internationally.  Forward-looking statements speak only as of the date hereof, and, except as required by law, AquaBounty undertakes no obligation to update or revise these forward-looking statements. For additional information regarding these and other risks faced by us, please refer to our public filings with the Securities and Exchange Commission (“SEC”), available on the Investors section of our website at www.aquabounty.com and on the SEC’s website at www.sec.gov.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the bonds described herein, nor shall there be any sale of these bonds in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.

Company Contact:
AquaBounty Technologies
Dave Conley
Corporate Communications
(613) 294-3078

Investor Relations:
Lucas A. Zimmerman
MZ Group - MZ North America
(949) 259-4987
AQB@mzgroup.us

AquaBounty Technologies, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)

 

 

 

 

 

 

 

 

June 30,

 

 

December 31,

 

2022

 

2021

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

118,888,889

 

 

$

88,454,988

 

Marketable securities

 

29,354,888

 

 

 

101,773,781

 

Inventory

 

1,918,395

 

 

 

1,259,910

 

Prepaid expenses and other current assets

 

4,447,399

 

 

 

1,536,484

 

Total current assets

 

154,609,571

 

 

 

193,025,163

 

 

 

 

 

 

 

Property, plant and equipment, net

 

63,978,895

 

 

 

33,815,119

 

Right of use assets, net

 

254,221

 

 

 

284,320

 

Intangible assets, net

 

224,991

 

 

 

231,842

 

Restricted cash

 

1,000,000

 

 

 

1,000,000

 

Other assets

 

72,083

 

 

 

79,548

 

Total assets

$

220,139,761

 

 

$

228,435,992

 

 

 

 

 

 

 

Liabilities and stockholders' equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued liabilities

$

6,883,125

 

 

$

4,317,615

 

Accrued employee compensation

 

783,449

 

 

 

874,589

 

Current debt

 

688,390

 

 

 

627,365

 

Other current liabilities

 

52,260

 

 

 

66,269

 

Total current liabilities

 

8,407,224

 

 

 

5,885,838

 

 

 

 

 

 

 

Long-term lease obligations

 

205,565

 

 

 

224,058

 

Long-term debt, net

 

8,114,797

 

 

 

8,523,333

 

Total liabilities

 

16,727,586

 

 

 

14,633,229

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

Common stock, $0.001 par value, 150,000,000 and 80,000,000 shares authorized at

 

 

 

 

 

June 30, 2022 and December 31, 2021, respectively; 71,110,713 and 71,025,738 shares

 

 

 

 

 

outstanding at June 30, 2022 and December 31, 2021, respectively

 

71,111

 

 

 

71,026

 

Additional paid-in capital

 

385,172,168

 

 

 

384,852,107

 

Accumulated other comprehensive loss

 

(318,554

)

 

 

(255,588

)

Accumulated deficit

 

(181,512,550

)

 

 

(170,864,782

)

Total stockholders' equity

 

203,412,175

 

 

 

213,802,763

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

$

220,139,761

 

 

$

228,435,992

 

 

 

 

 

 

 

 

 

AquaBounty Technologies, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2022

 

2021

 

2022

 

2021

Revenues

 

 

 

 

 

 

 

 

 

 

 

Product revenues

$

1,069,706

 

 

$

227,393

 

 

$

2,032,587

 

 

$

301,765

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses

 

 

 

 

 

 

 

 

 

 

 

Product costs

 

3,250,106

 

 

 

1,847,596

 

 

 

6,525,796

 

 

 

3,402,251

 

Sales and marketing

 

349,917

 

 

 

548,881

 

 

 

597,489

 

 

 

867,516

 

Research and development

 

208,292

 

 

 

431,373

 

 

 

375,481

 

 

 

931,993

 

General and administrative

 

2,831,930

 

 

 

2,578,958

 

 

 

5,208,166

 

 

 

4,364,468

 

Total costs and expenses

 

6,640,245

 

 

 

5,406,808

 

 

 

12,706,932

 

 

 

9,566,228

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating loss

 

(5,570,539

)

 

 

(5,179,415

)

 

 

(10,674,345

)

 

 

(9,264,463

)

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(74,694

)

 

 

(80,210

)

 

 

(149,982

)

 

 

(159,014

)

Other income, net

 

109,191

 

 

 

28,888

 

 

 

176,559

 

 

 

33,849

 

Total other income (expense)

 

34,497

 

 

 

(51,322

)

 

 

26,577

 

 

 

(125,165

)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(5,536,042

)

 

$

(5,230,737

)

 

$

(10,647,768

)

 

$

(9,389,628

)

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive (loss) income:

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation (loss) gain

 

(153,602

)

 

 

65,924

 

 

 

(70,697

)

 

 

145,963

 

Unrealized gain on marketable securities

 

121,796

 

 

 

8,970

 

 

 

7,731

 

 

 

8,970

 

Total other comprehensive (loss) income

 

(31,806

)

 

 

74,894

 

 

 

(62,966

)

 

 

154,933

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive loss

$

(5,567,848

)

 

$

(5,155,843

)

 

$

(10,710,734

)

 

$

(9,234,695

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

$

(0.08

)

 

$

(0.07

)

 

$

(0.15

)

 

$

(0.14

)

Weighted average number of Common Shares -

 

 

 

 

 

 

 

 

 

 

 

basic and diluted

 

71,068,671

 

 

 

71,021,141

 

 

 

71,036,562

 

 

 

67,803,904

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AquaBounty Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)

 

 

 

 

 

 

 

Six Months Ended June 30,

 

2022

 

2021

Operating activities

 

 

 

 

 

Net loss

$

(10,647,768

)

 

$

(9,389,628

)

Adjustment to reconcile net loss to net cash used in

 

 

 

 

 

operating activities:

 

 

 

 

 

Depreciation and amortization

 

988,292

 

 

 

857,842

 

Share-based compensation

 

318,608

 

 

 

217,069

 

Other non-cash charge

 

14,860

 

 

 

8,565

 

Changes in operating assets and liabilities:

 

 

 

 

 

Inventory

 

(661,090

)

 

 

(1,122,422

)

Prepaid expenses and other assets

 

(2,883,505

)

 

 

(876,139

)

Accounts payable and accrued liabilities

 

1,705,335

 

 

 

(150,951

)

Accrued employee compensation

 

(91,140

)

 

 

(2,169

)

Net cash used in operating activities

 

(11,256,408

)

 

 

(10,457,833

)

 

 

 

 

 

 

Investing activities

 

 

 

 

 

Purchases and deposits on property, plant and equipment

 

(30,472,704

)

 

 

(2,437,911

)

Maturities of marketable securities

 

120,047,915

 

 

 

139,542

 

Purchases of marketable securities

 

(47,621,291

)

 

 

(71,842,187

)

Other investing activities

 

12,500

 

 

 

(11,010

)

Net cash provided by (used in) investing activities

 

41,966,420

 

 

 

(74,151,566

)

 

 

 

 

 

 

Financing activities

 

 

 

 

 

Proceeds from issuance of debt

 

42,338

 

 

 

406,378

 

Repayment of term debt

 

(318,600

)

 

 

(79,600

)

Proceeds from the issuance of common stock, net

 

 

 

 

119,120,437

 

Proceeds from the exercise of stock options and warrants

 

1,538

 

 

 

1,723,846

 

Net cash (used in) provided by financing activities

 

(274,724

)

 

 

121,171,061

 

 

 

 

 

 

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

(1,387

)

 

 

32,529

 

Net change in cash, cash equivalents and restricted cash

 

30,433,901

 

 

 

36,594,191

 

Cash, cash equivalents and restricted cash at beginning of period

 

89,454,988

 

 

 

96,251,160

 

Cash, cash equivalents and restricted cash at end of period

$

119,888,889

 

 

$

132,845,351

 

 

 

 

 

 

 

Reconciliation of cash, cash equivalents and restricted cash reported

 

 

 

 

 

in the consolidated balance sheet:

 

 

 

 

 

Cash and cash equivalents

$

118,888,889

 

 

$

132,345,351

 

Restricted cash

 

1,000,000

 

 

 

500,000

 

Total cash, cash equivalents and restricted cash

$

119,888,889

 

 

$

132,845,351

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information and non-cash transactions:

 

 

 

 

 

Interest paid in cash

$

141,490

 

 

$

149,533

 

Property and equipment included in accounts payable and accrued liabilities

$

3,758,842

 

 

$

388,495

 



Advertisement